Core Viewpoint - The report discusses the achievement of the second vesting period conditions for the 2023 Restricted Stock Incentive Plan of Zhongwei Semiconductor Equipment (Shanghai) Co., Ltd, indicating that the necessary approvals and conditions have been met for the vesting of restricted stocks [1][3][4]. Summary by Sections Approval Process - The 2023 Restricted Stock Incentive Plan has undergone necessary approval procedures, including resolutions from the board and supervisory committee, and independent opinions from independent directors [1][3][4]. Conditions for Vesting - The second vesting period for the restricted stocks is defined as the period from the first trading day after 24 months from the grant date to the last trading day within 36 months from the grant date, specifically from June 12, 2025, to June 11, 2026 [3][4]. - The conditions for vesting have been met, including no adverse audit opinions, no administrative penalties on the incentive objects, and compliance with the required employment duration [3][4]. Performance Assessment - The company’s performance assessment for the vesting is based on the cumulative revenue growth rate compared to benchmark enterprises, with the 2023 revenue reported at 6,263.51 million yuan and the 2024 target at 9,065.17 million yuan, achieving a growth rate of 223.40% [3][4]. - The individual performance assessment for the incentive objects will determine the actual number of shares vested, categorized into five performance levels [4][5]. Conclusion - The independent financial advisor confirms that the vesting conditions for the second period have been achieved, and all necessary approvals have been obtained, complying with relevant laws and regulations [4][5].

Group 1 - The core point of the announcement is the self-examination report regarding insider trading related to the 2025 restricted stock incentive plan of Zhongwei Semiconductor Equipment (Shanghai) Co., Ltd. [1] - The company conducted a self-examination of insider trading activities among individuals with knowledge of the incentive plan prior to its public disclosure, confirming that no insider trading occurred [2][3] - A total of 9 individuals were found to have trading records during the self-examination period, but their transactions were based on independent market judgments and not related to insider information [2] Group 2 - The company adhered to relevant regulations and internal confidentiality measures during the planning of the incentive program, ensuring that only a limited number of personnel had access to insider information [2] - No instances of insider information leakage were identified prior to the public announcement of the incentive plan [2] - The self-examination concluded that all individuals with insider knowledge did not engage in insider trading or leak any related information [2]

Group 1 - The legal opinion letter was issued by Shanghai Jintiancheng Law Firm regarding the 2024 annual general meeting of Zhongwei Semiconductor Equipment (Shanghai) Co., Ltd. [1][2] - The meeting was convened by the company's board of directors on April 24, 2025, and the notice for the meeting was publicly disclosed on April 25, 2025, meeting the 20-day notice requirement [3][4] - The meeting took place on May 28, 2025, at 14:30, combining both on-site and online voting methods [3][5] Group 2 - A total of 503 shareholders and their proxies attended the meeting, representing 278,059,871 shares, which accounts for 44.4898% of the total voting shares [4][5] - The qualifications of the attendees, including shareholders, proxies, and company executives, were verified and deemed valid [4][5] Group 3 - The meeting reviewed 13 proposals, including the 2024 annual report, financial statements, profit distribution, and the appointment of the auditing firm for 2025 [5][6] - The voting process was conducted according to legal and regulatory requirements, with results announced immediately after the voting [6][7] Group 4 - The legal opinion concluded that the convening and conducting of the 2024 annual general meeting complied with relevant laws and regulations, and the voting results were valid [7]

Core Viewpoint - The legal opinion letter from Deheheng Law Firm confirms that Beijing Huafeng Measurement and Control Technology Co., Ltd.'s stock incentive plan has met the necessary conditions for the fourth vesting period and the third reserved grant period, along with adjustments to the grant price and the cancellation of certain restricted stocks [1][8][14]. Group 1: Approval and Authorization of the Incentive Plan - The incentive plan has been approved and authorized through various resolutions, including the draft of the 2021 Restricted Stock Incentive Plan and the assessment management measures [4][5][6]. - Independent directors and the supervisory board have provided opinions confirming that the incentive plan is beneficial for the company's sustainable development and does not harm the interests of shareholders [4][6]. Group 2: Vesting Conditions - The first vesting period for the incentive plan is set from May 27, 2021, to May 26, 2026, with specific conditions that must be met for the vesting to occur [8][11]. - The conditions for vesting include the absence of negative audit opinions on financial reports and compliance with legal regulations regarding profit distribution [8][10]. Group 3: Adjustments to Grant Price - The grant price has been adjusted due to changes in the company's profit distribution plan, with the new adjusted price being 66.65 RMB per share [13][14]. - The adjustment method follows the formula where the new price is calculated based on the previous price minus the dividend per share [13]. Group 4: Cancellation of Restricted Stocks - A total of 18,136 shares of restricted stock have been canceled due to the departure of one incentive object and the voluntary relinquishment of another [14]. - The board and supervisory board have agreed that the cancellation complies with relevant laws and does not harm shareholder interests [14]. Group 5: Information Disclosure Obligations - The company is required to disclose relevant documents related to the vesting, adjustment, and cancellation of stocks within two trading days following the board meetings [14]. - The company will continue to fulfill its legal obligations for information disclosure as the incentive plan progresses [14].

Core Viewpoint - The company is actively expanding its thin film deposition equipment business, with expectations for rapid revenue growth in the next three to five years, despite current revenue being relatively small [1][3]. Group 1: Thin Film Deposition Equipment - The company achieved its first sale of LPCVD equipment in 2024, with annual sales amounting to approximately 156 million yuan [2]. - The thin film deposition equipment market is segmented into various types, including LPCVD, PECVD, ALD, PVD, EPI, and others, with PECVD holding a 32% market share [3]. - The company has successfully developed multiple new LPCVD and ALD devices, with over 150 LPCVD reaction chambers shipped and EPI devices entering customer mass production verification [3]. Group 2: Erosion Equipment Development - The company has seen significant growth in its ICP equipment, with new orders reaching 2.168 billion yuan in 2023, a year-on-year increase of 139.3%, and 4.108 billion yuan in 2024, an increase of 89.5% [5]. - The company has reduced the product development cycle from 3-5 years to approximately 18 months, allowing for faster market entry and mass production [5]. - Historically, 70% to 75% of the company's R&D investment was allocated to etching equipment, but recent years have seen increased investment in thin film equipment development [5]. Group 3: Future Outlook - The company aims to cover over 60% of high-end semiconductor equipment in the next five to ten years, transitioning into a platform-style group company that includes etching, thin film, and measurement equipment [5].

Group 1 - The European Union (EU) officials have requested major EU companies and their CEOs to report detailed plans for investments in the United States to prepare for trade negotiations with the US [1][3] - The European Business Association members received a questionnaire from the European Commission, asking for their future investment intentions in the US [3] - The European Industrial Roundtable, which includes major companies like ASML, BASF, SAP, BMW, and Mercedes-Benz, has also been contacted to provide their investment plans for the next five years [3] Group 2 - Recent trade negotiations between the EU and the US show signs of progress, with President Trump delaying the imposition of a 50% tariff on EU imports from June 1 to July 9 [3][7] - The EU aims to negotiate the cancellation of any tariffs on EU products or at least prevent new tariffs, exploring conditions that could satisfy the US [7] - European companies are currently focusing significant investments in the pharmaceutical sector, with Roche and Novartis committing to invest $50 billion and $23 billion respectively in the US [7] Group 3 - A survey by the German Chamber of Commerce revealed that 24% of surveyed companies intend to increase investments in the US, while 29% plan to reduce their investments [7] - The uncertainty caused by the fluctuating policies of the Trump administration is a primary reason for companies considering reducing their investments in the US [7] - Trump's recent executive order requiring pharmaceutical companies to lower drug prices in the US has led Roche to reconsider further investments in the US [8]

Core Viewpoint - A-shares show resilience amid external market adjustments, indicating a strengthening internal trend supported by recent monetary policy changes and trade negotiations [1][2]. Market Outlook - The current market has largely priced in the tariff events and the first phase of trade negotiations, with a need for additional catalysts to break through March highs [2]. - The extreme drop on April 7 was a one-time reaction to the "equal tariffs" event, and the market has since undergone substantial recovery [2]. - Future challenges to March highs will require new policies, trade negotiation progress, or significant economic indicators [2]. Hot Sectors - June is expected to be driven by event-based thematic trading, with focus on low-position sectors like consumption and pharmaceuticals, as well as adjusted technology growth [3]. - Key areas of interest include: 1. Consumption expansion and domestic demand as a priority for 2025, with expectations for policy support in sectors like dairy, IP consumption, leisure tourism, and medical aesthetics [3]. 2. The trend of robot localization and integration into daily life, with opportunities in sensors, controllers, and dexterous hands [3]. 3. The ongoing trend of semiconductor localization, focusing on semiconductor equipment, wafer manufacturing, materials, and IC design [3]. 4. The military industry is expected to see order recovery by 2025, with signs of bottoming out in various sub-sectors [3]. 5. Innovative drugs are entering a recovery phase after four years of adjustment, with positive net profit growth expected to continue into 2025 [3]. Market Review - A-shares experienced narrow fluctuations with reduced trading volume, while consumption and pharmaceuticals rebounded [4]. - The market showed overall weakness, with 31 primary sectors exhibiting mixed performance, led by textiles, pharmaceuticals, beauty care, environmental protection, and real estate [4].

5月27日，省政协主席周波到沈阳市就民营经济发展进行调研。 省委常委、沈阳市委书记霍步刚参加调研。 沈阳东方钛业股份有限公司是国家级专精特新"小巨人"企业。周波走进企业展厅，详细了解企业发 展历程及现阶段生产经营情况，在车间实地查看企业核心产品，了解产品技术水平、出口销售等情况。 沈阳富创精密设备股份有限公司是国内半导体设备精密零部件领军企业。周波来到这里，与企业负责人 深入交流，走进生产车间，全面了解企业在产品研发、海内外业务布局、人才培养与激励等方面情况。 在辽宁成大生物股份有限公司，周波走进疫苗制剂车间，了解企业在人用狂犬病疫苗等领域的产品优 势，以及企业不断加大研发投入，加强核心技术攻关等方面情况。 周波来到浑南科技城，在智慧之云展厅了解科技城规划建设情况，特别是在创新平台、创新人才、 创新生态等方面深化改革，推动科技成果转移转化等方面的经验做法。在金科高新材料技术有限责任公 司，周波走进特种金属与高端部件技术创新中心，了解企业开展高纯原料、关键材料、核心零部件、成 套装备等产品研发及其产业化情况，鼓励企业发挥自身优势，立足自主创新，全力突破"卡脖子"问题， 提升我省高端制造业技术水平。 周波在调研中 ...

Core Viewpoint - The company, Zhongwei Semiconductor Equipment (Shanghai) Co., Ltd., reported significant growth in revenue and profit for 2024, with a focus on high R&D investment to enhance product competitiveness and market position by 2035 [1][2][3]. Financial Performance - In 2024, the company achieved operating revenue of 9.065 billion yuan, a year-on-year increase of 44.73%, maintaining an average annual growth rate of over 40% for nearly four years [1]. - The net profit attributable to shareholders, excluding non-recurring items, was approximately 1.388 billion yuan, reflecting a year-on-year growth of 16.51% [1]. - R&D investment reached 2.452 billion yuan in 2024, a 94.31% increase, accounting for about 27.05% of operating revenue [1]. R&D and Product Development - The company is currently developing over 20 new devices, including advanced plasma etching equipment and various deposition technologies [2]. - The time required to develop a new product has significantly decreased from 3-5 years to just 18 months, with mass production achievable within 6 to 12 months [2]. - The company aims to enhance its R&D capabilities to address external limitations and ensure smooth production lines domestically [2]. Market Position and Strategy - The global semiconductor industry is experiencing new growth opportunities driven by advancements in AI, cloud computing, and autonomous driving [3]. - The company focuses on high-quality development and aims to create differentiated, proprietary high-end equipment products while avoiding low-end competition [3]. - Since its IPO, the company has invested in over 30 upstream and downstream enterprises, achieving significant economic benefits and strategic synergies [3]. Supply Chain and Tariff Impact - The company has minimized reliance on U.S. suppliers for critical components, enhancing the localization of its supply chain [4]. - By developing high-quality suppliers and fostering domestic core suppliers, the company has improved its supply chain autonomy and resilience [4].

Summary of Zhongwei Company Conference Call Company Overview - Zhongwei Company reported a revenue growth of 35.4% in 2024, with a net profit of 1.39 billion yuan, representing a year-on-year increase of 16.5% [2][3] - The company’s core business is plasma etching equipment, which has maintained an average growth rate of over 50% over the past five years, with a growth of 49.4% in 2024 [2][6] - Zhongwei has developed three generations of 18 types of etching machines, covering 95% to 98% of application needs [2] Financial Performance - In Q1 2025, net profit increased by 13.4% year-on-year, indicating robust profitability and growth momentum [2][3] - R&D investment accounted for 27% of sales in 2024 and reached 31% in Q1 2025, significantly higher than the average of 10% to 15% for companies on the Sci-Tech Innovation Board [2][10] - Total assets reached 27.01 billion yuan, with net assets of 20.1 billion yuan and a low debt ratio [11] Industry Position and Strategy - The global semiconductor equipment market is approximately $100 billion, supporting the manufacturing of around $1 trillion worth of chips [4] - Zhongwei aims to increase its market share in high-end integrated circuit equipment from 30% to 60% over the next five to ten years [4][23] - The company has invested in 40 companies with a total investment of 2.29 billion yuan, currently valued at 5.9 billion yuan, with potential cash flow of about 8.3 billion yuan [4][30] Product Development and Innovation - Major products include photolithography machines, plasma etching machines, thin film equipment, and measurement devices, with plasma etching machines accounting for 70% to 75% of the market share [6][22] - Zhongwei has completed the development of 9 types of thin film equipment, with sales reaching 476 million yuan in 2023 and expected to exceed 180 units shipped in 2025 [2][18] - The company has innovated reactor designs to improve gas flow uniformity and doping concentration, enhancing equipment performance [2][20] Market Dynamics - The EPI equipment market has been dominated by two US companies, with Zhongwei successfully breaking this monopoly by developing its own Silicon Germanium and Silicon EPI equipment [19] - The company plans to expand into the wide bandgap semiconductor field, with significant progress in Silicon Carbide and Gallium Nitride power devices [26] Future Outlook - Zhongwei's future strategy includes organic growth and external expansion, aiming for high-quality development and to become a leading semiconductor equipment company by 2035 [41] - The company is also focusing on diversifying its business into other semiconductor-related fields to mitigate risks associated with the cyclical nature of integrated circuit investments [24][25] Additional Insights - Zhongwei has a strong R&D team of over 400 people, capable of developing over 20 new products annually, significantly reducing the time to market [12] - The company has received multiple awards for customer satisfaction and product quality, ranking third globally in overall customer evaluation [32][33] This summary encapsulates the key points from the conference call, highlighting Zhongwei Company's financial performance, industry position, product development, and future strategies.